Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection

Journal of Experimental Medicine

Volumn 211, Issue 5, 2014, Pages 961-974

  Srivastava, Shivani ^a,b   Koch, Meghan A ^a,b   Pepper, Marion ^b   Campbell, Daniel J ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; INTERFERON; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRAL CLEARANCE; VIRUS IMMUNITY; VIRUS INFECTION;

ADOPTIVE TRANSFER; ANIMALS; ARENAVIRIDAE INFECTIONS; DNA PRIMERS; FLOW CYTOMETRY; IMMUNITY, CELLULAR; INTERFERON TYPE I; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 84899746524     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131556     Document Type: Article

References (70)

1. Ahmed, R., A. Salmi, L.D. Butler, J.M. Chiller, and M.B. Oldstone. 1984. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J. Exp. Med. 160:521-540. http://dx.doi.org/10.1084/jem.160.2.521
2. Baccala, R., D.H. Kono, and A.N. Theofilopoulos. 2005. Interferons as pathogenic effectors in autoimmunity. Immunol. Rev. 204:9-26. http://dx.doi.org/10.1111/j.0105-2896.2005.00252.x
3. Belkaid, Y. 2007. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7:875-888. http://dx.doi.org/10.1038/nri2189
4. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of hostmicroorganism interactions*. Annu. Rev. Immunol. 27:551-589. http://dx.doi.org/10.1146/annurev.immunol.021908.132723
5. Benson, A., S. Murray, P. Divakar, N. Burnaevskiy, R. Pifer, J. Forman, and F. Yarovinsky. 2012. Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism. J. Immunol. 188:800-810. http://dx.doi.org/10.4049/jimmunol.1100769
6. Bolacchi, F., A. Sinistro, C. Ciaprini, F. Demin, M. Capozzi, F.C. Carducci, C.M. Drapeau, G. Rocchi, and A. Bergamini. 2006. Increased hepatitis C virus (HCV)-specific CD4+CD25+ regulatory T lymphocytes and reduced HCV-specific CD4+ T cell response in HCV-infected patients with normal versus abnormal alanine aminotransferase levels. Clin. Exp. Immunol. 144:188-196. http://dx.doi.org/10.1111/j.1365-2249.2006.03048.x
7. Boyman, O., M. Kovar, M.P. Rubinstein, C.D. Surh, and J. Sprent. 2006. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science. 311:1924-1927. http://dx.doi.org/10.1126/science.1122927
8. Bromberg, J.F., C.M. Horvath, Z. Wen, R.D. Schreiber, and J.E. Darnell Jr. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA. 93:7673-7678. http://dx.doi.org/10.1073/pnas.93.15.7673
9. Cabrera, R., Z. Tu, Y. Xu, R.J. Firpi, H.R. Rosen, C. Liu, and D.R. Nelson. 2004. An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection. Hepatology. 40:1062-1071. http://dx.doi.org/10.1002/hep.20454
10. Chen, M., G. Chen, S. Deng, X. Liu, G.J. Hutton, and J. Hong. 2012. IFN-? induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosis. J. Neuroimmunol. 242:39-46. http://dx.doi.org/10.1016/j.jneuroim.2011.10.014
11. Choi, Y.S., R. Kageyama, D. Eto, T.C. Escobar, R.J. Johnston, L. Monticelli, C. Lao, and S. Crotty. 2011. ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity. 34:932-946. http://dx.doi.org/10.1016/j.immuni.2011.03.023
12. Clark, R.A., and T.S. Kupper. 2007. IL-15 and dermal fibroblasts induce proliferation of natural regulatory T cells isolated from human skin. Blood. 109:194-202. http://dx.doi.org/10.1182/blood-2006-02-002873
13. Cretney, E., A. Xin, W. Shi, M. Minnich, F. Masson, M. Miasari, G.T. Belz, G.K. Smyth, M. Busslinger, S.L. Nutt, and A. Kallies. 2011. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat. Immunol. 12:304-311. http://dx.doi.org/10.1038/ni.2006
14. Cretney, E., A. Kallies, and S.L. Nutt. 2013. Differentiation and function of Foxp3+ effector regulatory T cells. Trends Immunol. 34:74-80. http://dx.doi.org/10.1016/j.it.2012.11.002
15. Dann, A., H. Poeck, A.L. Croxford, S. Gaupp, K. Kierdorf, M. Knust, D. Pfeifer, C. Maihoefer, S. Endres, U. Kalinke, et al. 2012. Cytosolic RIG-I-like helicases act as negative regulators of sterile inflammation in the CNS. Nat. Neurosci. 15:98-106. http://dx.doi.org/10.1038/nn.2964
16. Darrasse-Jèze, G., S. Deroubaix, H. Mouquet, G.D. Victora, T. Eisenreich, K.H. Yao, R.F. Masilamani, M.L. Dustin, A. Rudensky, K. Liu, and M.C. Nussenzweig. 2009. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 206:1853-1862. http://dx.doi.org/10.1084/jem.20090746
17. De Andrés, C., C. Aristimuño, V. de Las Heras, M.L. Martínez-Ginés, M. Bartolomé, R. Arroyo, J. Navarro, S. Giménez-Roldán, E. Fernández- Cruz, and S. Sánchez-Ramón. 2007. Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis. J. Neuroimmunol. 182:204-211. http://dx.doi.org/10.1016/j.jneuroim.2006.09.012
18. DiPaolo, R.J., D.D. Glass, K.E. Bijwaard, and E.M. Shevach. 2005. CD4+CD25+ T cells prevent the development of organ-specific autoimmune disease by inhibiting the differentiation of autoreactive effector T cells. J. Immunol. 175:7135-7142.
19. Firan, M., S. Dhillon, P. Estess, and M.H. Siegelman. 2006. Suppressor activity and potency among regulatory T cells is discriminated by functionally active CD44. Blood. 107:619-627. http://dx.doi.org/10.1182/blood-2005-06-2277
20. Fulton, R.B., D.K. Meyerholz, and S.M. Varga. 2010. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 185:2382-2392. http://dx.doi.org/10.4049/jimmunol.1000423
21. Gil, M.P., R. Salomon, J. Louten, and C.A. Biron. 2006. Modulation of STAT1 protein levels: a mechanism shaping CD8 T-cell responses in vivo. Blood. 107:987-993. http://dx.doi.org/10.1182/blood-2005-07-2834
22. Gil, M.P., M.J. Ploquin, W.T. Watford, S.H. Lee, K. Kim, X. Wang, Y. Kanno, J.J. O'Shea, and C.A. Biron. 2012. Regulating type 1 IFN effects in CD8 T cells during viral infections: changing STAT4 and STAT1 expression for function. Blood. 120:3718-3728. http://dx.doi.org/10.1182/blood-2012-05-428672
23. Golding, A., A. Rosen, M. Petri, E. Akhter, and F. Andrade. 2010. Interferonalpha regulates the dynamic balance between human activated regulatory and effector T cells: implications for antiviral and autoimmune responses. Immunology. 131:107-117.
24. Goodman, T., and L. Lefrancois. 1989. Intraepithelial lymphocytes. Anatomical site, not T cell receptor form, dictates phenotype and function. J. Exp. Med. 170:1569-1581. http://dx.doi.org/10.1084/jem.170.5.1569
25. Hänig, J., and M.B. Lutz. 2008. Suppression of mature dendritic cell function by regulatory T cells in vivo is abrogated by CD40 licensing. J. Immunol. 180:1405-1413.
26. Havenar-Daughton, C., G.A. Kolumam, and K. Murali-Krishna. 2006. Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J. Immunol. 176:3315-3319.
27. Herman, A.E., G.J. Freeman, D. Mathis, and C. Benoist. 2004. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199:1479-1489. http://dx.doi.org/10.1084/jem.20040179
28. Hisaeda, H., Y. Maekawa, D. Iwakawa, H. Okada, K. Himeno, K. Kishihara, S. Tsukumo, and K. Yasutomo. 2004. Escape of malaria parasites from host immunity requires CD4+ CD25+ regulatory T cells. Nat. Med. 10:29-30. http://dx.doi.org/10.1038/nm975
29. Homann, D., L. Teyton, and M.B. Oldstone. 2001. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat. Med. 7:913-919. http://dx.doi.org/10.1038/90950
30. Huehn, J., K. Siegmund, J.C. Lehmann, C. Siewert, U. Haubold, M. Feuerer, G.F. Debes, J. Lauber, O. Frey, G.K. Przybylski, et al. 2004. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199:303-313. http://dx.doi.org/10.1084/jem.20031562
31. Iwai, H., M. Abe, S. Hirose, F. Tsushima, K. Tezuka, H. Akiba, H. Yagita, K. Okumura, H. Kohsaka, N. Miyasaka, and M. Azuma. 2003. Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol. 171:2848-2854.
32. Kolumam, G.A., S. Thomas, L.J. Thompson, J. Sprent, and K. Murali- Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202:637-650. http://dx.doi.org/10.1084/jem.20050821
33. Lee, S.E., X. Li, J.C. Kim, J. Lee, J.M. González-Navajas, S.H. Hong, I.K. Park, J.H. Rhee, and E. Raz. 2012. Type I interferons maintain Foxp3 expression and T-regulatory cell functions under inflammatory conditions in mice. Gastroenterology. 143:145-154. http://dx.doi.org/10.1053/j.gastro.2012.03.042
34. Long, M., and A.J. Adler. 2006. Cutting edge: Paracrine, but not autocrine, IL-2 signaling is sustained during early antiviral CD4 T cell response. J. Immunol. 177:4257-4261.
35. Luft, T., K.C. Pang, E. Thomas, P. Hertzog, D.N. Hart, J. Trapani, and J. Cebon. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947-1953.
36. Lund, J.M., L. Hsing, T.T. Pham, and A.Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science. 320:1220-1224. http://dx.doi.org/10.1126/science.1155209
37. McCausland, M.M., and S. Crotty. 2008. Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo. J. Virol. Methods. 147:167-176. http://dx.doi.org/10.1016/j.jviromet.2007.08.025
38. Mempel, T.R., M.J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U.H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity. 25:129-141. http://dx.doi.org/10.1016/j.immuni.2006.04.015
39. Min, B., A. Thornton, S.M. Caucheteux, S.A. Younes, K. Oh, J. Hu-Li, and W.E. Paul. 2007. Gut flora antigens are not important in the maintenance of regulatory T cell heterogeneity and homeostasis. Eur. J. Immunol. 37:1916-1923. http://dx.doi.org/10.1002/eji.200737236
40. Mozzillo, N., and P. Ascierto. 2012. Reduction of circulating regulatory T cells by intravenous high-dose interferon alfa-2b treatment in melanoma patients. Clin. Exp. Metastasis. 29:801-805. http://dx.doi.org/10.1007/s10585-012-9504-2
41. Müller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264:1918-1921. http://dx.doi.org/10.1126/science.8009221
42. Murali-Krishna, K., J.D. Altman, M. Suresh, D.J. Sourdive, A.J. Zajac, J.D. Miller, J. Slansky, and R. Ahmed. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity. 8:177-187. http://dx.doi.org/10.1016/S1074-7613(00) 80470-7
43. Namdar, A., B. Nikbin, M. Ghabaee, A. Bayati, and M. Izad. 2010. Effect of IFN-? therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study. J. Neuroimmunol. 218:120-124. http://dx.doi.org/10.1016/j.jneuroim.2009.10.013
44. Nguyen, K.B., T.P. Salazar-Mather, M.Y. Dalod, J.B. Van Deusen, X.Q. Wei, F.Y. Liew, M.A. Caligiuri, J.E. Durbin, and C.A. Biron. 2002. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169:4279-4287.
45. O'Sullivan, B.J., H.E. Thomas, S. Pai, P. Santamaria, Y. Iwakura, R.J. Steptoe, T.W. Kay, and R. Thomas. 2006. IL-1? breaks tolerance through expansion of CD25+ effector T cells. J. Immunol. 176:7278-7287.
46. Pace, L., S. Vitale, B. Dettori, C. Palombi, V. La Sorsa, F. Belardelli, E. Proietti, and G. Doria. 2010. APC activation by IFN-? decreases regulatory T cell and enhances Th cell functions. J. Immunol. 184:5969-5979. http://dx.doi.org/10.4049/jimmunol.0900526
47. Pace, L., A. Tempez, C. Arnold-Schrauf, F. Lemaitre, P. Bousso, L. Fetler, T. Sparwasser, and S. Amigorena. 2012. Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science. 338:532-536. http://dx.doi.org/10.1126/science.1227049
48. Pasare, C., and R. Medzhitov. 2003. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 299:1033-1036. http://dx.doi.org/10.1126/science.1078231
49. Petricoin, E.F. III, S. Ito, B.L. Williams, S. Audet, L.F. Stancato, A. Gamero, K. Clouse, P. Grimley, A. Weiss, J. Beeler, et al. 1997. Antiproliferative action of interferon-? requires components of T-cell-receptor signalling. Nature. 390:629-632. http://dx.doi.org/10.1038/37648
50. Prinz, M., H. Schmidt, A. Mildner, K.P. Knobeloch, U.K. Hanisch, J. Raasch, D. Merkler, C. Detje, I. Gutcher, J. Mages, et al. 2008. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 28:675-686. http://dx.doi.org/10.1016/j.immuni.2008.03.011
51. Riley, C.H., M.K. Jensen, M.K. Brimnes, H.C. Hasselbalch, O.W. Bjerrum, P.T. Straten, and I.M. Svane. 2011. Increase in circulating CD4+CD25+Foxp3+ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-?. Blood. 118:2170-2173. http://dx.doi.org/10.1182/blood-2011-03-340992
52. Rowe, J.H., J.M. Ertelt, M.N. Aguilera, M.A. Farrar, and S.S. Way. 2011. Foxp3+ regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe. 10:54-64. http://dx.doi.org/10.1016/j.chom.2011.06.005
53. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell. 133:775-787. http://dx.doi.org/10.1016/j.cell.2008.05.009
54. Sarween, N., A. Chodos, C. Raykundalia, M. Khan, A.K. Abbas, and L.S. Walker. 2004. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173:2942-2951.
55. Serra, P., A. Amrani, J. Yamanouchi, B. Han, S. Thiessen, T. Utsugi, J. Verdaguer, and P. Santamaria. 2003. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+CD25+ T cells. Immunity. 19:877-889. http://dx.doi.org/10.1016/S1074-7613(03)00327-3
56. Shafiani, S., C. Dinh, J.M. Ertelt, A.O. Moguche, I. Siddiqui, K.S. Smigiel, P. Sharma, D.J. Campbell, S.S. Way, and K.B. Urdahl. 2013. Pathogenspecific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity. 38:1261-1270. http://dx.doi.org/10.1016/j.immuni.2013.06.003
57. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M.P. Schön, A. Scheffold, J.B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood. 106:3097-3104. http://dx.doi.org/10.1182/blood- 2005-05-1864
58. Simpson, T.R., S.A. Quezada, and J.P. Allison. 2010. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr. Opin. Immunol. 22:326-332. http://dx.doi.org/10.1016/j.coi.2010.01.001
59. Sojka, D.K., and D.J. Fowell. 2011. Regulatory T cells inhibit acute IFN-? synthesis without blocking T-helper cell type 1 (Th1) differentiation via a compartmentalized requirement for IL-10. Proc. Natl. Acad. Sci. USA. 108:18336-18341. http://dx.doi.org/10.1073/pnas.1110566108
60. Tanabe, Y., T. Nishibori, L. Su, R.M. Arduini, D.P. Baker, and M. David. 2005. Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-αβ responses in T lymphocytes. J. Immunol. 174:609-613.
61. Tanaka, S., S. Maeda, M. Hashimoto, C. Fujimori, Y. Ito, S. Teradaira, K. Hirota, H. Yoshitomi, T. Katakai, A. Shimizu, et al. 2010. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J. Immunol. 185:2295-2305. http://dx.doi.org/10.4049/jimmunol.1000848
62. Tang, Q., K.J. Henriksen, E.K. Boden, A.J. Tooley, J. Ye, S.K. Subudhi, X.X. Zheng, T.B. Strom, and J.A. Bluestone. 2003. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171:3348-3352.
63. Teijaro, J.R., C. Ng, A.M. Lee, B.M. Sullivan, K.C. Sheehan, M. Welch, R.D. Schreiber, J.C. de la Torre, and M.B. Oldstone. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science. 340:207-211. http://dx.doi.org/10.1126/science.1235214
64. Theofilopoulos, A.N., R. Baccala, B. Beutler, and D.H. Kono. 2005. Type I interferons (?/?) in immunity and autoimmunity. Annu. Rev. Immunol. 23:307-335. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115843
65. Trinchieri, G. 2010. Type I interferon: friend or foe? J. Exp. Med. 207:2053-2063. http://dx.doi.org/10.1084/jem.20101664
66. Williams, M.A., A.J. Tyznik, and M.J. Bevan. 2006. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature. 441:890-893. http://dx.doi.org/10.1038/nature04790
67. Wilson, E.B., D.H. Yamada, H. Elsaesser, J. Herskovitz, J. Deng, G. Cheng, B.J. Aronow, C.L. Karp, and D.G. Brooks. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 340:202-207. http://dx.doi.org/10.1126/science.1235208
68. Xia, J., W. Liu, B. Hu, Z. Tian, and Y. Yang. 2010. IL-15 promotes regulatory T cell function and protects against diabetes development in NKdepleted NOD mice. Clin. Immunol. 134:130-139. http://dx.doi.org/10.1016/j.clim.2009.09.011
69. Zhang, X., S. Sun, I. Hwang, D.F. Tough, and J. Sprent. 1998. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity. 8:591-599. http://dx.doi.org/10.1016/S1074-7613(00)80564-6
70. Zhao, J., J. Zhao, C. Fett, K. Trandem, E. Fleming, and S. Perlman. 2011. IFN-?- and IL-10-expressing virus epitope-specific Foxp3+ T reg cells in the central nervous system during encephalomyelitis. J. Exp. Med. 208:1571-1577. http://dx.doi.org/10.1084/jem.20110236